BioSyent (CVE:RX) Sets New 12-Month High – Here’s Why

BioSyent Inc. (CVE:RX) shares reached a new 52-week high on Monday . The stock traded as high as C$11.74 and last traded at C$11.74, with a volume of 4577 shares. The stock had previously closed at C$11.25.

BioSyent Trading Down 0.1 %

The company has a debt-to-equity ratio of 3.19, a quick ratio of 6.91 and a current ratio of 6.13. The business’s 50 day moving average price is C$11.08 and its 200-day moving average price is C$10.32. The firm has a market cap of C$133.40 million, a price-to-earnings ratio of 19.20 and a beta of 0.93.

BioSyent (CVE:RX) last announced its quarterly earnings data on Monday, August 26th. The company reported C$0.13 earnings per share (EPS) for the quarter, meeting the consensus estimate of C$0.13. The firm had revenue of C$8.95 million for the quarter, compared to analysts’ expectations of C$8.80 million. BioSyent had a return on equity of 20.88% and a net margin of 21.14%. Equities analysts expect that BioSyent Inc. will post 0.6944444 EPS for the current year.

Insider Activity at BioSyent

In other BioSyent news, Director Seyed Ahmad Ashrafi sold 2,320 shares of the firm’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of C$10.95, for a total value of C$25,404.00. Also, insider FAX Capital Corp. sold 230,800 shares of BioSyent stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of C$11.12, for a total value of C$2,566,496.00. In the last ninety days, insiders have sold 234,357 shares of company stock valued at $2,605,854. Corporate insiders own 33.65% of the company’s stock.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.